Hongfei Chen Selected Research

Hongfei Chen Research Topics

Disease

15	Neoplasms (Cancer) 04/2024 - 12/2015
6	Cardiotoxicity 12/2021 - 12/2011
4	Heart Arrest (Cardiac Arrest) 11/2019 - 12/2011
3	Breast Neoplasms (Breast Cancer) 11/2023 - 11/2021
3	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 12/2016
2	Weight Gain 05/2024 - 01/2024
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023 - 09/2020
2	Reperfusion Injury 04/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2015
2	Acute Lung Injury 01/2021 - 01/2018
1	Atrial Fibrillation 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 05/2022
1	Brain Ischemia (Cerebral Ischemia) 04/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021
1	Cushing Syndrome 01/2021
1	Osteoarthritis 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Atherosclerosis 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Wounds and Injuries (Trauma) 01/2021

Drug/Important Bio-Agent (IBA)

7	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2021 - 12/2011
4	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 11/2016
3	Photosensitizing Agents (Photosensitizers)IBA 04/2024 - 01/2022
3	LipidsIBA 04/2024 - 01/2014
3	EmulsionsIBA 11/2018 - 12/2011
2	AntibodiesIBA 04/2024 - 12/2023
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2021
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 12/2022
2	Toll-Like Receptor 7IBA 12/2022 - 01/2022
2	Estrogens (Estrogen)FDA Link 05/2022 - 02/2022
2	MicroRNAs (MicroRNA)IBA 12/2021 - 09/2020
2	Circular RNAIBA 12/2021 - 12/2020
2	Epinephrine (Adrenaline)FDA LinkGeneric 11/2018 - 04/2015
2	MethyltransferasesIBA 05/2017 - 11/2016
1	Oxygen (Dioxygen)IBA 05/2024
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 04/2024
1	NitrogenIBA 01/2024
1	EnzymesIBA 11/2023
1	LigandsIBA 01/2023
1	arginyl-glycyl-aspartic acidIBA 01/2023
1	MagnesiumIBA 01/2023
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2023
1	mouse MIRN29 microRNAIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 12/2022
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 12/2022
1	Pattern Recognition ReceptorsIBA 12/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2022
1	CurcuminIBA 10/2022
1	PolymersIBA 08/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 08/2022
1	CamptothecinIBA 08/2022
1	MicellesIBA 08/2022
1	AcidsIBA 08/2022
1	Estrogen ReceptorsIBA 05/2022
1	Sevoflurane (Ultane)FDA LinkGeneric 04/2022
1	ErbB Receptors (EGF Receptor)IBA 02/2022
1	amsonic acid (DAS)IBA 02/2022
1	allyl sulfideIBA 02/2022
1	AminesIBA 01/2022
1	cupric sulfide (CuS)IBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	AntigensIBA 01/2022
1	Differentiation AntigensIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	CalciumIBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	CateninsIBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2021
1	polyvinylidene fluoride (PVDF)IBA 12/2021
1	Ion Channels (Ion Channel)IBA 12/2021
1	polyacrylamideIBA 12/2021
1	Sirolimus (Rapamycin)FDA Link 12/2021
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 12/2021
1	Bovine Serum AlbuminIBA 12/2021
1	AlpelisibIBA 11/2021
1	idelalisibIBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	duvelisibIBA 11/2021
1	AmidesIBA 10/2021
1	Adenosine Monophosphate (AMP)IBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 10/2021
1	Mitochondrial DNA (mtDNA)IBA 10/2021
1	Local AnestheticsIBA 10/2021
1	apelin-13 peptideIBA 10/2021
1	mitoquinoneIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021

Therapy/Procedure

6	Immunotherapy 12/2023 - 01/2022
5	Therapeutics 08/2022 - 09/2020
2	Transplantation 09/2020 - 01/2019
2	Resuscitation 11/2018 - 12/2011
1	Drug Therapy (Chemotherapy) 11/2023
1	Photothermal Therapy 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Lasers (Laser) 01/2022
1	Intravenous Administration 01/2021